rs201904720

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004614.5(TK2):​c.122C>T​(p.Pro41Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000148 in 1,353,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P41H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 8.3e-7 ( 0 hom. )

Consequence

TK2
NM_004614.5 missense, splice_region

Scores

1
6
12
Splicing: ADA: 0.2141
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.160

Publications

4 publications found
Variant links:
Genes affected
TK2 (HGNC:11831): (thymidine kinase 2) This gene encodes a deoxyribonucleoside kinase that specifically phosphorylates thymidine, deoxycytidine, and deoxyuridine. The encoded enzyme localizes to the mitochondria and is required for mitochondrial DNA synthesis. Mutations in this gene are associated with a myopathic form of mitochondrial DNA depletion syndrome. Alternate splicing results in multiple transcript variants encoding distinct isoforms, some of which lack transit peptide, so are not localized to mitochondria. [provided by RefSeq, Dec 2012]
TK2 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial DNA depletion syndrome, myopathic form
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive progressive external ophthalmoplegia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25608104).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TK2NM_004614.5 linkc.122C>T p.Pro41Leu missense_variant, splice_region_variant Exon 1 of 10 ENST00000544898.6 NP_004605.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TK2ENST00000544898.6 linkc.122C>T p.Pro41Leu missense_variant, splice_region_variant Exon 1 of 10 1 NM_004614.5 ENSP00000440898.2

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152182
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
8.32e-7
AC:
1
AN:
1201720
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
582416
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24076
American (AMR)
AF:
0.00
AC:
0
AN:
10896
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16230
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28626
South Asian (SAS)
AF:
0.00
AC:
0
AN:
46010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29552
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3338
European-Non Finnish (NFE)
AF:
0.00000101
AC:
1
AN:
993694
Other (OTH)
AF:
0.00
AC:
0
AN:
49298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152182
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41462
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
May 03, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals with TK2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces proline with leucine at codon 41 of the TK2 protein (p.Pro41Leu). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and leucine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
9.4
DANN
Uncertain
0.99
DEOGEN2
Benign
0.33
T;.;T;.;.;T;.
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.72
T;T;.;T;T;T;T
M_CAP
Pathogenic
0.78
D
MetaRNN
Benign
0.26
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.33
D
MutationAssessor
Benign
1.7
L;L;L;.;L;.;.
PhyloP100
0.16
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.76
N;.;.;.;N;N;.
REVEL
Benign
0.27
Sift
Uncertain
0.0070
D;.;.;.;T;T;.
Sift4G
Benign
0.25
T;T;T;T;T;T;T
Polyphen
0.035
B;.;B;.;.;.;.
Vest4
0.11
MutPred
0.28
.;.;.;Loss of glycosylation at P83 (P = 0.0062);.;.;Loss of glycosylation at P83 (P = 0.0062);
MVP
0.91
MPC
0.36
ClinPred
0.97
D
GERP RS
-0.044
PromoterAI
-0.0080
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.054
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.21
dbscSNV1_RF
Benign
0.38
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201904720; hg19: chr16-66583843; API